Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance. Lu E, Wang B W, Guimond C, Synnes A, Sadovnick DA, Dahlgren L, Traboulsee A, Tremlett H Expert Rev Neurother. 2013 Mar; 13(3):251-61. PMID: 23448215. Abstract CommentRecommendBookmarkWatch